You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. COVID-19

SYNE-COV for predicting COVID-19 outcomes

  • Medtech innovation briefing
  • Reference number: MIB264
  • Published:  15 June 2021

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

SYNE‑COV has obtained UK Conformity Assessed (UKCA) marking.


Next page Equality considerations Previous page The technology
Back to top